LAUREN STEPHENS: Open Payments
NPI 1932874963 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,264 in 221 payments from 21 companies in 2025. Trend: 2023 $4,321 · 2024 $5,177 · 2025 $4,264
Food & beverage: $4,264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $619 |
| UCB, Inc. | 27 | $553 |
| GENZYME CORPORATION | 14 | $339 |
| Lilly USA, LLC | 15 | $334 |
| Janssen Biotech, Inc. | 18 | $331 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $322 |
| Regeneron Healthcare Solutions, Inc. | 9 | $243 |
| LEO Pharma Inc. | 14 | $242 |
| Novartis Pharmaceuticals Corporation | 14 | $225 |
| E.R. Squibb & Sons, L.L.C. | 14 | $184 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, TALTZ, RINVOQ, ILUMYA, Sotyktu.
Industry payments across NE — which companies pay providers there.
